Lysergic acid diethylamide (Mind Medicine/The University Hospital of Basel)

麦角二乙胺 (Mind Medicine/The University Hospital of Basel)

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameLysergic acid diethylamide (Mind Medicine/The University Hospital of Basel)
Drug Alias NameD-lysergic acid diethylamide d-Tartrate (Mind Medicine)麦角酸二乙胺LSD (Mind Medicine/The University Hospital of Basel)麦角酸二乙酰胺LSD D-tartrate +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor partial agonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityDepressive Disorder, MajorAnxiety Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesPoland +[8] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe University Hospital of Basel
China Registration ClassN/A

Develop Information

Active CompaniesMind Medicine IncDefinium Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with HyperactivityDepressive Disorder, MajorAnxiety Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia